FDA Approves Merz Aesthetics’ Xeomin for Smoothing Moderate to Severe Upper Facial Lines
The U.S. Food and Drug Administration (FDA) approved XEOMIN (incobotulinumtoxinA) for the simultaneous treatment of forehead lines, frown lines, and crow’s feet. XEOMIN is also indicated for the temporary improvement in the appearance of moderate to severe glabellar lines. The total recommended XEOMIN dose for treatment is 20 units for glabellar frown lines, 20 units for […]